Aspen Pharmacare | APN - Cash And Equivalent


Aspen Pharmacare reported ZAR5.62B in Cash and Equivalent for its fiscal semester ending in December of 2025.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 5.62B 789M Dec/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Kalbe Farma IDR 4.05T 245.07B Sep/2025
Life Healthcare ZAR 2.8B 1.65B Dec/2022
Netcare ZAR 1.5B 109M Dec/2022
Richter Gedeon HUF 135.63B 61.59B Dec/2024